- $10.19bn
- $10.68bn
- $1.98bn
- 98
- 46
- 71
- 84
Annual income statement for Qiagen NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,870 | 2,252 | 2,142 | 1,965 | 1,978 |
| Cost of Revenue | |||||
| Gross Profit | 1,233 | 1,451 | 1,385 | 1,234 | 1,262 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,484 | 1,622 | 1,610 | 1,560 | 1,881 |
| Operating Profit | 386 | 630 | 531 | 406 | 97.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 439 | 626 | 513 | 430 | 121 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 359 | 513 | 423 | 341 | 83.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 359 | 513 | 423 | 341 | 83.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 359 | 513 | 423 | 341 | 83.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.12 | 2.45 | 2.12 | 1.71 | 1.64 |